Microglial-to-neuronal CCR5 signaling regulates autophagy in neurodegeneration
Year: 2023
Type: article
Abstract: In neurodegenerative diseases, microglia switch to an activated state, which results in excessive secretion of pro-inflammatory factors. Our work aims to investigate how this paracrine signaling affects neuronal function. Here, we show that activated microglia mediate non-cell-autonomous inhibition of neuronal autophagy, a degradative pathway critical for the removal of toxic, aggregate-prone proteins accumulating in neurodegenerative diseases. We found that the microglial-derived CCL-3/-4/-5 bind and activate neuronal CCR5, which in turn promotes mTORC1 activation and disrupts autophagy and aggregate-prone protein clearance. CCR5 and its cognate chemokines are upregulated in the brains of pre-manifesting mouse models for Huntington's disease (HD) and tauopathy, suggesting a pathological role of this microglia-neuronal axis in the early phases of these diseases. CCR5 upregulation is self-sustaining, as CCL5-CCR5 autophagy inhibition impairs CCR5 degradation itself. Finally, pharmacological or genetic inhibition of CCR5 rescues mTORC1 hyperactivation and autophagy dysfunction, which ameliorates HD and tau pathologies in mouse models.
Source: Neuron
Institutions: University of Cambridge, UK Dementia Research Institute
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $9,080
Funders: Wellcome Trust, Alzheimer's Society, National Institute for Health and Care Research, European Commission, Alzheimer’s Research UK, Institut Pasteur, UK Dementia Research Institute, National Institutes of Health, Tau Consortium, Medical Research Council, Horizon 2020, NIHR Cambridge Biomedical Research Centre, H2020 Marie Skłodowska-Curie Actions
OpenAlex ID: W4367056702
